NewsRx

Search our medical news database

Cardiovascular Therapy

Lentiviral vectors can transduce human heart cells

Published in Gene Therapy Weekly, October 17th, 2002

by Sonia Nichols, senior medical writer - Some of the best delivery vehicles for cardiac-directed gene therapies could be lentiviral vectors.

In one of the first studies of its kind, researchers in the United Kingdom have demonstrated lentiviral vectors can successfully transfer genes to human heart muscle cells, or cardiomyocytes.

Human immunodeficiency virus (HIV) type 1 is a lentivirus. Using pseudotyped HIV-1, Zing Zhao and colleagues, University of Cambridge, have developed constructs containing reporter genes and other genetic materials, testing the constructs for transfer efficiency both in vitro and in vivo.

"We...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook